[ET Net News Agency, 21 June 2024] CARDIOFLOW-B (02160) fell 3.4% to HK$0.84.
It hits an intra-day low of HK$0.81, hitting a historical low, and an intra-day high of
HK$0.88. The total shares traded was 1.4 million, with a value of HK$1.19m. The active
buy/sell ratio is 36:64, with net selling turnover of HK$314,690. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$29,631, with volume weighted
average price of HK$0.86. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$152,306, with volume weighted average price of HK$0.86. The stock
has fallen a combined 6.7% over the past 2 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 0.840 % Chg -3.45%
High 0.880 Low 0.810
Shares Tr 1.4m Turnover 1.19m
10-D SMA 0.918 %H.V 30.410
20-D SMA 0.962 VWAP 0.851
50-D SMA 1.016 RSI14 21.963
--------------------------------
Status: Hitting a historical low, active buy/sell ratio is 36:64, with net selling
turnover of HK$314,690, falling a combined 6.7% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 0.84 -3.45
GENSCRIPT BIO (01548) 8.50 -1.28
INNOVENT BIO (01801) 37.00 -0.40
EVEREST MED-B (01952) 19.94 -0.30
WUXI BIO (02269) 11.62 -0.85
WUXI APPTEC (02359) 30.65 -1.13
BEIGENE (06160) 93.30 +0.27
ASCENTAGE-B (06855) 24.95 -0.40
AKESO (09926) 35.30 -0.56
PEIJIA-B (09996) 2.95 +2.79
---------------------------------------------
(ed)